Skip to Content

Duopa Approval History

  • FDA approved: Yes (First approved January 12th, 2015)
  • Brand name: Duopa
  • Generic name: carbidopa and levodopa
  • Dosage form: Enteral Suspension
  • Company: AbbVie Inc.
  • Treatment for: Parkinson's Disease

Duopa (carbidopa and levodopa) is an aromatic amino acid decarboxylation inhibitor and aromatic amino acid combination formulated as an enteral suspension for the treatment of motor fluctuations in patients with advanced Parkinson’s disease.

Development History and FDA Approval Process for Duopa

Jan 12, 2015Approval FDA Approves Duopa (carbidopa and levodopa) Enteral Suspension for Parkinson's Disease

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.